ShavetaVinayakMD

PubMed

• Publisher's Note to Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline (...
  Simona F Shaitelman, Bethany M Anderson, Douglas W Arthur, Jose G Bazan, Jennifer R Bellon, Lisa Bradfield, Charlotte E Coles, Naamit K Gerber, Madeera Kathpal, Leonar...> ;Practical Radiation Oncology. 2023 Nov 18
• 8 citations
  Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.
  Simona F Shaitelman, Bethany M Anderson, Douglas W Arthur, Jose G Bazan, Jennifer R Bellon, Lisa Bradfield, Charlotte E Coles, Naamit K Gerber, Madeera Kathpal, Leonar...> ;Practical Radiation Oncology. 2023 Nov 15
• Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
  Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Elife. 2023 Oct 17
• 1 citations
  Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
  Lauren Lenz, Chris Neff, Cara Solimeno, Elizabeth S Cogan, Vandana G Abramson, Judy C Boughey, Carla Falkson, Matthew P Goetz, James M Ford, William J Gradishar, Rache...> ;Breast Cancer Research and Treatment. 2023 Nov 1
• 2 citations
  Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
  Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Medrxiv. 2023 Mar 10
• 3 citations
  Emerging strategies: PARP inhibitors in combination with immune checkpoint blockade in BRCA1 and BRCA2 mutation-associated and triple-negative breast cancer.
  Tanya Gupta, Shaveta Vinayak, Melinda Telli> ;Breast Cancer Research and Treatment. 2023 Jan 1
• 23 citations
  Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or H...
  Beverly Moy, R. Bryan Rumble, Steven E. Come, Nancy E. Davidson, Angelo Di Leo, Julie R. Gralow, Gabriel N. Hortobagyi, Douglas Yee, Ian E. Smith, Mariana Chavez-MacGr...> ;Journal of Clinical Oncology. 2021 Jul 29
• 1 citations
  Selection of Adjuvant Endocrine Therapy for Women With Breast Cancer in Menopausal Transition: Is It Simpler Than We Thought?
  Shaveta Vinayak, Nancy E. Davidson> ;Journal of the National Cancer Institute. 2021 Nov 2
• 22 citations
  A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Cancer Cell. 2020 Dec 14
• 215 citations
  TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
  Nadine Tung, Mark E. Robson, Steffen Ventz, Cesar A. Santa-Maria, Rita Nanda, Paul K. Marcom, Payal D. Shah, Tarah J. Ballinger, Eddy S. Yang, Shaveta Vinayak, Michell...> ;Journal of Clinical Oncology. 2020 Oct 29
• 35 citations
  5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers
  Yiqing Zhao, Xiujing Feng, Yicheng Chen, J. Eva Selfridge, Shashank Gorityala, Zhanwen Du, Janet Wang, Yujun Hao, Gino Cioffi, Ronald A. Conlon, Jill S. Barnholtz-Sloa...> ;Cancer Research. 2020 Nov 1
• 18 citations
  Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Poole...
  Melinda L. Telli, Charles Chu, Sunil Badve, Shaveta Vinayak, Daniel P. Silver, Steven J. Isakoff, Virginia G. Kaklamani, William J. Gradishar, Vered Stearns, Roisin M....> ;Clinical Cancer Research. 2020 Jun 1
• 4 citations
  BRCA Mutations and Homologous Recombination Repair Deficiency in Treatment With Niraparib Combined With Pembrolizumab-Reply.
  Panagiotis A. Konstantinopoulos, Shaveta Vinayak> ;JAMA Oncology. 2020 Mar 1
• 4 citations
  Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?
  Shaveta Vinayak, Nancy E. Davidson> ;Oncology. 2019 Jun 19
• 243 citations
  Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.
  Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg, Monica M. Mita, Georgia A. McCann, Antoinette R. Tan, Andrea E. Wahner-Hendrickson, Andres Forero, Carey K. Ande...> ;JAMA Oncology. 2019 Jun 13
• 5 citations
  Future of checkpoint blockade in triple-negative breast cancer: combination strategies to lead the way.
  Melinda L. Telli, Shaveta Vinayak> ;Annals of Oncology. 2019 Mar 1
• 69 citations
  Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated...
  Melinda L. Telli, Jessica A. Hellyer, William Audeh, Kristin C. Jensen, Shikha Bose, Kirsten Timms, Alexander Gutin, Victor Abkevich, Rebecca N. Peterson, Chris Neff, ...> ;Breast Cancer Research and Treatment. 2018 Apr 1
• A breast multi-disciplinary genomic tumor board is feasible and can provide timely and impactful recommendations.
  Karen Tsung, Cheryl L. Thompson, Joy Knight, Steve Maximuk, Navid Sadri, Hannah Gilmore, Ruth A. Keri, Shaveta Vinayak, Lyndsay Harris, Paula Silverman> ;The Breast Journal. 2018 Mar 8
• 82 citations
  Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
  Mary R. Doherty, Hyeon Joo Cheon, Damian J. Junk, Shaveta Vinayak, Vinay Varadan, Melinda L. Telli, James M. Ford, George Stark Stark, Mark W. Jackson> ;Proceedings of the National Academy of Sciences of the United States of America. 2017 Dec 26
• 14 citations
  Role of Platinum in Early-Stage Triple-Negative Breast Cancer.
  Alyssa A. La Belle, Jude Khatib, William P. Schiemann, Shaveta Vinayak> ;Current Treatment Options in Oncology. 2017 Nov 6
• 41 citations
  Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance
  Anosheh Afghahi, Kirsten Timms, Shaveta Vinayak, Kristin C. Jensen, Allison W. Kurian, Robert W. Carlson, Pei-Jen Chang, Elizabeth A. Schackmann, Anne-Renee Hartman, J...> ;Clinical Cancer Research. 2017 Jul 1
• 488 citations
  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
  Mary B. Daly, Robert Pilarski, Michael Berry, Saundra S. Buys, Meagan Farmer, Susan Hatters Friedman, Judy Garber, Noah D. Kauff, Seema A. Khan, Catherine Klein, Wendy...> ;Journal of the National Comprehensive Cancer Network. 2017 Jan 1
• 7 citations
  Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab.
  Jahnavi Gollamudi, Jenny G. Parvani, William P. Schiemann, Shaveta Vinayak> ;Cancer Management and Research. 2016 Feb 18
• 74 citations
  18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
  Stephanie Avril, Raymond F. Muzic, Donna Plecha, Bryan Traughber, Shaveta Vinayak, Norbert Avril> ;Journal of Nuclear Medicine. 2016 Feb 1
• 80 citations
  Genomic complexity profiling reveals that HORMAD1 overexpression contributes to homologous recombination deficiency in triple-negative breast cancers
  Johnathan Watkins, Daniel Weekes, Vandna Shah, Patrycja Gazinska, Shalaka Joshi, Bhavna Sidhu, Cheryl Gillett, Sarah E Pinder, Fabio Vanoli, Maria Jasin, Markus Mayrho...> ;Cancer Discovery. 2015 May 1
• Join now to see all

Lectures

• TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial. Breast Cancer Immunotherapy: Ca... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018